MT Newswires05-19
The Trendlines (SGX:42T) signed a strategic distribution agreement with a US-based medical technology company, according to a Monday filing with the Singapore Exchange.
Shares of the company were down nearly 2% in Tuesday trading.
Under the agreement, the company's brand, ElastiMed will gain access to the US market for its MyoSleeve wearable compression device.
MyoSleeve's technology aims at the treatment of venous and lymphatic conditions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
